Lexaria Bioscience (LEXX) Ownership - Who owns Lexaria Bioscience?
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEXX showed earnings on July 18, 2025. You can read more about the earnings report here.